Clinical Trial Update: Clostridium Butyricum in Stenosing Crohn's Desease [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating Clostridium butyricum in patients with stenosing Crohn's disease is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Clostridium butyricum (Clostridium butyricum)

Snippet

Sponsor: San Giovanni Addolorata Hospital | Conditions: Crohn Disease (CD) | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING